You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 1, January 3, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Oral Contraceptives and Risk of Breast Cancer in Women With a Family History of Breast Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Ms Grabrick and colleagues1 suggest that the risk of breast cancer from oral contraceptive (OC) use is related to estrogen use. They state, "The amount of estrogen in OCs has decreased from an initial 150 µg to 50 µg or less currently. . . ." However, the original 1960s "pill," Enovid, contained many times that amount of estrogen. I can find no studies on the risk of breast cancer from Enovid use. If the risk is in fact dose-related, that would seem an obvious "natural experiment."

Larry R. Kirkland, MD
Department of Medicine
Emory University School of Medicine
Atlanta, Ga

1. Grabrick DM, Hartmann LC, Cerhan JR, et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000;284:1791-1798. FREE FULL TEXT


To the Editor: The findings of Ms Grabrick and colleagues1 strengthen the results of previous studies showing that women who have used OCs and have a family history (first degree female relative) of breast cancer may be at higher risk of developing breast cancer themselves. However, because . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of Hormone Levels in Nipple Aspirate Fluid of Pre- and Postmenopausal Women: Effect of Oral Contraceptives and Hormone Replacement
Chatterton et al.
J. Clin. Endocrinol. Metab. 2005;90:1686-1691.
ABSTRACT | FULL TEXT  

Prophylactic Oophorectomy and Hormone Replacement Therapy: Protection at What Price?
Garber and Hartman
JCO 2004;22:978-980.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.